| CAT No: | CL-EPF-01 |
| CAS No: | NA |
| Mol.F: | C35H49N11O9S2 |
| Mol.Wt.: | 832 |
| Rel. Cas No: | |
| Chemical Name: | 2-((3S,11S,17S,20S,25aS)-20-((1H-indol-3-yl)methyl)-3-carbamoyl-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo[2,1-g][1,2]dithia[5,8,11,14,17,20]hexaazacyclotricosin-17-yl)acetic acid |
| SMILES: | Smiles Not Available |
| Inventory Status: | Custom synthesis |
This impurity is related to 6-D-Cys Eptifibatide is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
6-D-Cys Eptifibatide is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:2-((3S,11S,17S,20S,25aS)-20-((1H-indol-3-yl)methyl)-3-carbamoyl-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo[2,1-g][1,2]dithia[5,8,11,14,17,20]hexaazacyclotricosin-17-yl)acetic acidCountry of Origin: India Product Category: PeptidesAPI NAME: Eptifibatide Molecular Formula: C35H49N11O9S2
Molecular Weight: 832
Storage: Store in a cool, dry place.
| Product Name: | 6-D-Cys Eptifibatide |
| CAS No: | |
| Mol.F.: | C35H49N11O9S2 |
| Mol.Wt.: | 832 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: